secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2023-01-18T23:59:59+00:00
Accession:  0001493152-23-001795
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma subsidiary Nexcella raises ~$650k in private placement at $6.49/share
--------------------------------------------------------------------------------

- Nexcella entered share purchase agreements with accredited investors for 100,152 shares at $6.49/share.
- Gross proceeds of approximately $650,000; after closing, Nexcella has 6,357,444 shares outstanding.
- Offering exempt under Section 4(a)(2) and Rule 506 of Regulation D; shares are restricted securities.
- Shares subject to drag-along rights and potential 365-day lock-up upon any future IPO of the subsidiary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315223001795/0001493152-23-001795-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315223001795/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-001795

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer